• Elanco Animal Health director Lawrence Erik Kurzius reported a purchase of 40,000 common shares at USD 23.4 each.
• Directly held stake rose to 188,647 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001352090-26-000006), on August 21, 2026, and is solely responsible for the information contained therein.